Publication: Additive Value of EBUS-TBNA for Staging Non-Small Cell Lung Cancer in Patients Evaluated for Stereotactic Body Radiation Therapy
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.extent
10 p.
item.page.accessRights
Acceso abierto
item.page.other
item.page.references
Abstract
Background/Objectives: Patients with non-small cell lung cancer (NSCLC) being evaluated for stereotactic body radiation therapy (SBRT) are frequently staged non-invasively with positron emission tomog...
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
Boster, J. M., Goertzen, S. M., Sainz, P. V., Vial, M. R., Zaveri-Desai, J. K., Luna, L. D., Waqar, A., Grosu, H. B., Casal, R. F., Jimenez, C. A., Ost, D. E., Sabath, B. F., Lin, J., Hernandez, M., & Eapen, G. A. (2025). Additive Value of EBUS-TBNA for Staging Non-Small Cell Lung Cancer in Patients Evaluated for Stereotactic Body Radiation Therapy. Diagnostics, 15(17), 2136. https://doi.org/10.3390/diagnostics15172136
item.page.dc.rights
item.page.dc.rights.url
Estadísticas de uso
6 5 3 2 0
Febrero 2026Marzo 2026Abril 2026Mayo 2026Junio 2026Julio 2026Agosto 2026